IDPC and GDPO acknowledge the wealth of data in the World Drug Report, whilst critiquing its overly positive outlook on the impact of drug control efforts and law enforcement approaches.
Perrina et al. discuss the impact of stigmatising attitudes toward drug userspeople who use drugs and sellers on women, highlighting policy barriers toward inclusion.
O’Gorman and Schatz outline benefits of partnerships between civil society and political institutions to address the harm reduction needs of people who use drug.
Ten years after the adoption of the Bangkok Rules, countries have largely failed to implement them, while the number of women in prison has risen dramatically.
A coalition of civil society organisations underscores the importance of developing strategies for resilience and resistance in the face of government attacks.
The BMZ identifies obstacles and opportunities in the provision of alternative livelihoods, including through the cultivation of cannabis for medical purposes.
Moshenska and Shelly argue archaeologies of drug use can shed light on both local public health practices and lived experiences, and the impact of national and international laws on drug use.
Wisse et al. argue that adaptations in the drug response in relation to COVID-19 should pave the way for positive and sustainable change in the health and criminal justice systems.
Hiller-Sturmhoefel's study also suggests African Americans with a recent substance use disorder diagnosis were twice as likely to acquire COVID-19 than their white counterparts.
HRW's flagship publication includes multiple accounts on how countries around the world weaponise drug control to supress dissent and undermine human rights.
